ArticleBMC public health2026
Study protocol for a quasi-experimental investigation of the effectiveness of the 'CATCH My Breath' vaping prevention curriculum at preventing vaping outcomes among high school students in Ontario, Canada.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06825338 (Investigating the Effectiveness of the 'CATCH My Breath' Vaping Prevention Curriculum at Preventing Vaping Initiation Among High School Students in Ontario, Canada), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Investigating the Effectiveness of the 'CATCH My Breath' Vaping Prevention Curriculum at Preventing Vaping Initiation Among High School Students in Ontario, Canada
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundVaping is prevalent among youth in Canada, and youth who vape are at risk of becoming addicted to nicotine and continuing to vape. Given these risks, there is a need to identify effective prevention approaches. The goal of this study is to investigate the effectiveness of the 'CATCH My Breath' (CMB) vaping prevention curriculum at preventing vaping outcomes among a cohort of high school students in Ontario, Canada.
methodsThis quasi-experimental study will use a non-equivalent control group pretest-posttest design. A purposive sample of 28 high schools in Ontario, Canada will be recruited, and a trained presenter will deliver the CMB curriculum to grade 9 students during selected classes. CMB is a school-based vaping prevention curriculum with demonstrated success in the United States that incorporates theory to foster social competence and social influence resistance skills. Students in the intervention group will complete online surveys before exposure to the curriculum, and 3- and 12-months later to identify changes in vaping knowledge and attitudes, susceptibility to vaping among non-vapers, vaping initiation, and current vaping. These data will be compared to a matched sample of school- and student-level data from the COMPASS study, an ongoing longitudinal cohort study of youth health behaviours. Descriptive analysis of baseline data will produce a profile of demographics and baseline characteristics and identify any imbalances between the intervention and comparison groups that should be accounted for in later analyses. Multilevel regression models will test for intervention effects while controlling for baseline differences through the use of covariates. DISCUSSION: To our knowledge, there are no published studies demonstrating that a vaping program can prevent vaping initiation among high school students. As a result, there is not enough evidence for schools to confidently implement programs that address vaping. Given the demand from Canadian high schools for vaping prevention programming, there is a need to further examine the impact of CMB to inform program recommendations to schools.
trial registrationThis study has been registered with ClinicalTrials.gov on Feb 7, 2025 (NCT06825338).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.